ArticleJournal of thoracic disease2018

Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine.

Peng Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.